Morpholino antisense oligonucleotides targeting a splice site in ClC-1 was able to reverse the ClC-1 alternative splicing defect in skeletal muscle and eliminate myotonia in two mouse models of DM1 [23]. This evidence concerns the gene CLCN1 and myotonic dystrophy type 1.